Who invested in Eureka Therapeutics?
Eureka Therapeutics's investors include Majuven, Yuan Capital, Acorn Campus, Harbinger Venture Capital and Suma Venture.

United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$21Mraised across 1 round since 2014, from 1 source
From a historical funding recordSEC filing: $21M sold, first sale Aug 2014
From Eureka Therapeutics's own website and the SEC filings it signed: 9 on the team.
On the board, as filediBo D. FengWai-Yan ""Sandy"" D. ChauWilliam S. Solari
AdvisersReginald Seeto
Eureka Therapeutics's investors include Majuven, Yuan Capital, Acorn Campus, Harbinger Venture Capital and Suma Venture.
Eureka Therapeutics has raised $21M across 1 round since 2014.
Eureka Therapeutics's most recent round was a Series C of $21M in Sept 2014.
Its most recent round, $21M in Sept 2014, is also its largest on record.
Eureka Therapeutics's first round on record, in Sept 2014, was backed by Majuven, Yuan Capital and Acorn Campus and 2 others.
Eureka Therapeutics's latest named round is a Series C, in Sept 2014.
Eureka Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.